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Defects in the cilia gene RPGRIP1 cause Leber congenital amaurosis and cone-rod dystrophy in humans. A
form of canine cone-rod dystrophy (cord1) was originally associated with a homozygous insertion in
RPGRIP1 (RPGRIP1ins/ins) as the primary disease locus while a homozygous deletion in MAP9(MAP9del/
del) was later identified as a modifier associated with the early onset form. However, we find further variability
in cone electroretinograms (ERGs) ranging from normal to absent in an extended RPGRIP1ins/ins canine
colony, irrespective of the MAP9 genotype. Ophthalmoscopically, cone ERGabsentRPGRIP1ins/ins eyes show
discolouration of the tapetal fundus with varying onset and disease progression, while sd-OCT reveals
atrophic changes. Despite marked changes in cone ERG and retinal morphology, photopic vision-guided
behaviour is comparable between normal and cone ERGabsentRPGRIP1ins/ins littermates. Cone morphology
of the dogs lacking cone ERG are truncated with shortened outer and inner segments.
Immunohistochemically, cone ERGabsentRPGRIP1ins/ins retinas have extensive L/M-opsin mislocalization,
lack CNGB3 labelling in the L/M-cones, and lack GC1 in all cones. Our results indicate that cord1 is a
multigenic disease in which mutations in neither RPGRIP1 nor MAP9 alone lead to visual deficits, and
additional gene(s) contribute to cone-specific functional and morphologic defects.
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Variabilities in retinal function 
and structure in a canine model 
of cone-rod dystrophy associated 
with RPGRIP1 support multigenic 
etiology
Rueben G. Das, Felipe Pompeo Marinho, Simone Iwabe, Evelyn Santana, Kendra Sierra McDaid, 
Gustavo D. Aguirre & Keiko Miyadera
Defects in the cilia gene RPGRIP1 cause Leber congenital amaurosis and cone-rod dystrophy in humans. 
A form of canine cone-rod dystrophy (cord1) was originally associated with a homozygous insertion in 
RPGRIP1 (RPGRIP1ins/ins) as the primary disease locus while a homozygous deletion in MAP9 (MAP9del/del) 
was later identified as a modifier associated with the early onset form. However, we find further variability 
in cone electroretinograms (ERGs) ranging from normal to absent in an extended RPGRIP1ins/ins canine 
colony, irrespective of the MAP9 genotype. Ophthalmoscopically, cone ERGabsent RPGRIP1ins/ins eyes show 
discolouration of the tapetal fundus with varying onset and disease progression, while sd-OCT reveals 
atrophic changes. Despite marked changes in cone ERG and retinal morphology, photopic vision-guided 
behaviour is comparable between normal and cone ERGabsent RPGRIP1ins/ins littermates. Cone morphology of 
the dogs lacking cone ERG are truncated with shortened outer and inner segments. Immunohistochemically, 
cone ERGabsent RPGRIP1ins/ins retinas have extensive L/M-opsin mislocalization, lack CNGB3 labelling in 
the L/M-cones, and lack GC1 in all cones. Our results indicate that cord1 is a multigenic disease in which 
mutations in neither RPGRIP1 nor MAP9 alone lead to visual deficits, and additional gene(s) contribute to 
cone-specific functional and morphologic defects.
The photic environment has played a significant role in retinal evolution in animals, as the size of the retina and 
the density and population of photoreceptors (rods and cones) adapt to changes in habitat illumination1. Cone 
photoreceptors aid in photopic (bright light) and colour vision and promote visual acuity while rods primarily 
function in scotopic (dim light) condition. Although cones constitute only 3–5% of the total photoreceptors in the 
human retina, they are used more frequently than rods, as we are less likely to be exposed to the dark in the mod-
ern world. Therefore, cone-rod dystrophies (CRDs), a form of inherited degenerative retinal disorders that result 
in an initial loss of cones and in which rod impairment is either delayed or reduced, are particularly devastating.
Photoreceptors consist of an inner segment (IS) and an outer segment (OS) that are connected by a narrow 
photoreceptor sensory cilium. Proper functioning of photoreceptors requires continual transport of proteins, 
lipids, and metabolites from the IS to OS through the cilia2, followed by rapid renewal of the OS as it is subse-
quently shed and phagocytized by the retinal pigment epithelium (RPE). Hence, disruption of cone-derived, 
photopic vision can be caused by defects in cone structure and/or function, including alterations in the transport 
of key macromolecules across the cones.
The cone-predominant nature of CRDs manifests as decreased central visual acuity and defects in col-
our vision. With further disease progression, dysfunction involves the rods, eventually leading to blindness3. 
Cone-rod dystrophy 1 (cord1) is a canine form of CRD previously described in a miniature long-haired dachs-
hund (MLHD) research colony where the disease segregated autosomal recessively4. Affected pups had fundus 
abnormalities, such as granular tapetum that developed retinal thinning and vascular attenuation by 25 weeks 
of age. The cone-derived electroretinogram (ERG) was greatly reduced at this stage, while the rod-derived ERG 
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remained normal, despite signs of degeneration. By 40 weeks, the retina was severely degenerated, with unde-
tectable cone- or rod-derived ERGs5. This research colony was used to map a disease-specific 14 Mb interval6 
that was further narrowed down to 1.74Mb7 on canine chromosome 15. Among the positional candidate genes, 
retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGRIP1) was found to harbour a homozygous 
44 bp insertion (RPGRIP1ins/ins) in exon 2 (now revised to exon 3; CanFam3.1) that segregated with cord1 in 
the colony6. While the insertion was initially predicted to result in a frame shift and protein truncation6, it was 
later shown that exon skipping occurs, allowing the main functional domain RID (RPGR-interacting domain) to 
remain intact8.
Despite the apparent straightforward monogenic role for RPGRIP1 for causation of cord1 in the MLDH 
research colony, a significant proportion of RPGRIP1ins/ins MLHDs outside of the original research colony did 
not develop early-onset blindness, but instead were affected at a much later age, or remained clinically normal 
throughout life7. Furthermore, dogs of other breeds such as English Springer spaniel, Labrador retriever and 
French bulldog also harbour the RPGRIP1 insertion, but are clinically unaffected7,8. Based on the discordance 
between RPGRIP1 genotype and clinical phenotype, a genome-wide association study was undertaken that iden-
tified a locus ~30 kb downstream of RPGRIP1 on canine chromosome 15 that influenced the age of onset of severe 
retinal degeneration or clinical blindness9. Recently, targeted-sequencing of this locus identified a ~22 kb deletion 
spanning part of the gene encoding microtubule associated protein 9 (MAP9) and the neighbouring MAP9 partial 
pseudogene10. This deletion leads to a fusion transcript MAP9EORD containing several deleterious variants at the 
region corresponding to the 3′UTR of MAP9.
While mutations in RPGRIP1 and MAP9 have been linked to cord1, accurate prediction of disease onset is still 
challenging. To study the disease course in genotype-ascertained dogs, we developed an out crossed canine colony 
whose founders included an RPGRIP1ins/ins MLHD from the original research colony in the UK8. Interestingly, 
none of the RPGRIP1ins/ins progeny developed clinical blindness by up to age 8 years. Despite the lack of visual 
defects, there was a distinct and marked difference in photopic cone-derived ERG that ranged from normal to 
reduced (cone ERGreduced) or complete absence (cone ERGabsent) in these dogs. To tease out the factor responsible 
for this spectrum of cone responses, we examined the retinal structure by ophthalmoscopy, spectral domain 
Figure 1. Segregation of RPGRIP1 and MAP9 mutations and phenotypic variability in the canine pedigree 
studied. Four unrelated dogs including three MLHDs (Casper, R9 and R10) founded the research colony. The 
symbols indicate the cone ERG status ranging from normal, reduced to absent, and clinical blindness. Below 
each symbol, the RPGRIP1 (top) and MAP9 (bottom) genotypes are shown where “i” and “d” represent the 
mutant alleles respectively. Animals that contributed to IHC, behaviour, qPCR, or Western blot studies are 
indicated with black, red, blue, or green asterisks respectively. Double homozygotes (RPGRIP1ins/insMAP9del/del) 
are indicated with open arrows. Square, male; circle, female.
www.nature.com/scientificreports/
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Figure 2. Representative ERG responses and vision-guided behaviour among RPGRIP1ins/ins animals. (a,b) 
ERG responses to light stimuli occurring at the time points indicated by bold triangles, for each right (black) 
and left (blue) eyes. (a1) Representative cone-ERG 29 Hz flicker responses of RPGRIP1ins/ins animals with either 
MAP9+/+ or MAP9+/del are displayed in increasing order of ERG amplitude. The cone ERG phenotype ranges 
from absent to normal in both MAP9 genotypic groups. (a2) Representative cone 29 Hz flicker ERG traces 
of MAP9del/del animals with and without concomitant RPGRIP1ins/ins mutation. All the double homozygotes 
(RPGRIP1ins/insMAP9del/del) in the colony were cone ERGabsent. (b1) ERG traces of RPGRIP1ins/insMAP9+/del  
littermates R42 and R46 at 5 yrs are shown. Single flash cone-derived ERG response was normal in R42 
(“normal”) but diminished in R46 (“cone ERGabsent”). Rod-derived and mixed ERG responses were comparable 
between the animals. (b2) Sequential cone-derived 29 Hz flicker responses are shown at 11, 27, and 60 mon 
where the normal (R42) and absent (R46) cone responses have remained stable over time. (c) Graphical 
representation of transit times (sec) in a vision-guided obstacle course in normal (R42) and cone ERGabsent 
(R46) animals under increasing illuminations (lux) are illustrated per observation time point. Visual function 
of these sibs has been shown previously at 6, 8 and 10 mon8 and therefore this is an extended study on both 
animals. Over the 5-year period, there was no difference in the transit time between the dogs at any of the 
light intensities. Each transit time shown is the average of three trials through an obstacle course under each 
illumination. Error bars represent ± SD.
www.nature.com/scientificreports/
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Figure 3. Normal retina in the first year with slow retinal degenerative changes observed at later age in some 
RPGRIP1ins/ins dogs. (a) Differential interference contrast (DIC) (left) and H&E-stained (right) images of WT, 
RPGRIP1+/ins, and RPGRIP1ins/ins (normal or cone ERGabsent) retinas at 9–11 mon were comparable without overt 
structural abnormality. RPE, retinal pigmented epithelium; OS, outer segment; IS, inner segment; ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion 
cell layer. (b) ONL thickness was quantitated by counting the rows of nuclei (/558μm length) at 2,400, 7,200, 
and 10,500 μm distances from the ora serrata. H&E-stained sections from WT (n = 3), RPGRIP1+/ins (n = 2), 
and RPGRIP1ins/ins (3 normal, 3 cone ERGabsent) retinas at 9–11 mon were used. Error bars represent standard 
errors for groups of n = 3, and ranges (dotted line) in the group of n = 2. (c) Spider graphs of ONL thickness 
along the inferosuperior retina transversing the optic nerve, measured by manual segmentation from sd-OCT 
B-scans. Changes over time in each eye of a double homozygote RPGRIP1ins/insMAP9del/del (R62; cone ERGabsent) 
from 10 through 30 mon are shown. Progressive ONL thinning that is more pronounced in the inferior retina 
www.nature.com/scientificreports/
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optical coherence tomography (sd-OCT) and/or immunolabelling, and retinal function by ERG and vision-guided 
behaviour in RPGRIP1ins/ins mutants. Herein we report our findings that support a multigenic basis for cord1.
Results
Normal rod-derived but variable cone-derived ERG in RPGRIP1ins/ins animals. The earliest sign of 
cord1 uniformly observed in the original research colony was the reduction of cone-derived ERG5. In a recent 
study, an age-at-onset modifier was identified in MAP99,10. To assess both rod and cone function in the current 
pedigree (Fig. 1), ERGs were recorded in RPGRIP1ins/ins animals as well as in RPGRIP1+/ins controls. Scotopic 
rod-derived ERG did not show any consistent or significant reduction across the different RPGRIP1 genotypes. 
However, photopic cone-derived ERG (1 Hz and 29 Hz) varied significantly among RPGRIP1ins/ins animals, rang-
ing from normal to reduced or completely absent (Fig. 2a). Extensive variation was observed within and across 
different litters, and this was independent of the MAP9 genotype (Supplemental Table 3, Figs 1 and 2a). While 
the cone ERGabsent phenotype was seen among RPGRIP1ins/ins dogs of all MAP9 genotypes, notably, all the double 
homozygotes (RPGRIP1ins/insMAP9del/del; n = 6) fell into the cone ERGabsent phenotype (Fig. 2a2). Those dogs that 
were homozygous for MAP9 but not for RPGRIP1 (i.e. RPGRIP1+/insMAP9del/del) had normal cone ERG (Fig. 2a2). 
There was no difference in rod-derived ERG responses across the RPGRIP1ins/ins dogs of all MAP9 genotypes 
(Fig. 2b1). ERG findings remained largely consistent over time when repeated (Fig. 2b2), and none of the animals 
in the extreme phenotypic groups changed status to the other phenotypic extreme (e.g. from normal to cone 
ERGabsent, and vice versa). Assessment of each L/M- and S-cone function in normal, cone ERGreduced, and cone 
ERGabsent animals showed that L/M- and S-cone ERGs were equally affected in the latter two groups, the cone 
ERGs of which were abnormal (Supplemental Fig. S1).
Normal visual performance in cone ERGabsent RPGRIP1ins/ins animals. To assess both photopic 
and scotopic visual functions, two littermates (RPGRIP1ins/insMAP9+/del) that were either normal (R42) or cone 
ERGabsent (R46) were run through an obstacle avoidance course under different light intensity conditions period-
ically over a 5.5- year period (Fig. 2c; Supplemental Video 1). This pair had previously been studied at a younger 
age (6 through 10 months)8. Throughout the study period, the transit times remained comparable between the 
two animals. Furthermore, none of the 12 RPGRIP1ins/ins animals observed for over 2 years in the research colony 
developed clinically appreciable vision impairment or blindness up to ages 7.3 (normal) and 8 (cone ERGabsent) 
years.
Normal retinal structure at early age but progressive degenerative changes at later age in some 
RPGRIP1ins/ins animals. To study the structure of the RPGRIP1ins/ins retina, histology was performed in 
young eyes, while extended in vivo observation were performed in other animals. RPGRIP1ins/ins retinas with the 
extreme phenotypes (i.e. normal or cone ERGabsent) were used to increase the chance of identifying any changes. 
Retinal morphology studied by H&E staining was comparable across all the groups: wild type (WT) (n = 3; 2–5 
yrs), RPGRIP1+/ins (n = 1; 9 mon), and RPGRIP1ins/ins that were normal (n = 2; 9–11 mon) or cone ERGabsent (n = 3; 
9–11 mon) (Fig. 3a). There was no significant difference in ONL thickness in the superior and inferior retinal 
quadrants among the groups (Fig. 3b).
Although typical early retinal degenerative changes had been observed ophthalmoscopically in the 
RPGRIP1ins/ins founder animals (i.e. Casper, R10), all the subsequent RPGRIP1ins/ins progeny were found to have 
normal fundus in early life. However, with age, some cone ERGabsent mutants developed dark discoloration of the 
tapetal fundus, typically appearing as “mottled” dark areas extending from the superior tapetal-nontapetal junc-
tion (Fig. 3f). These occasionally coalescing darker regions were more extensive in the far superior fundus. Areas 
adjacent to the dark colouration had increased reflectivity from the underlying tapetum, indicating thinning of 
the retina. A variant of the fundus change in the form of irregular circular lesions against the dark discoloured 
background was also observed (Fig. 3g). In the non-tapetal fundus, multifocal patchy depigmentation was seen 
in some retinas (Fig. 3h). There was significant variability in the onset, progression, and appearance of the fundus 
lesions. While only a few RPGRIP1ins/ins animals have been followed into later age thus far, age-related progressive 
fundus changes were observed exclusively in the cone ERGabsent retinas. For example, when comparing a cone 
ERGabsent animal with its normal littermate harbouring identical genotypes (RPGRIP1ins/insMAP9+/del), the former 
was found to have developed more prominent dark superior discoloration by 5 years of age (Fig. 3i). While fur-
ther longitudinal data are required to draw an association between the genotypes and fundus lesions, there was a 
is observed in both eyes. (d,e) Changes in retinal/ONL thickness imaged by sd-OCT in the superotemporal 
(d, ST), area centralis (e, AC) and inferonasal (e) retinal areas in the double homozygote shown in (c). The 
left eye is shown and the arrows in the left cSLO image indicate the position of scanning. Progressive retinal/
ONL thinning is observed in all retinal areas and is most pronounced in the inferonasal quadrant. Progressive 
vascular attenuation (arrow heads) was evident in the inferonasal scan (e). (f) Fundus changes over time in the 
double homozygote shown in (c–e). The tapetal fundus remained within normal limits until 20 mon. However, 
by 27 mon, dark discoloration had advanced from the superior periphery. Vascular attenuation and hyper-
reflectivity were also noticed. (g) Fundus lesions in the right eye of an RPGRIP1ins/insMAP9+/del dog (R48, cone 
ERGseverely reduced) observed at 5 yrs. Multifocal circular lesions (magnified in inset) present across the tapetal 
fundus were condensed nasally. (h) Multifocal depigmentation in the far inferior non-tapetal fundus in the left 
eye of an RPGRIP1ins/insMAP9+/del dog (R28, cone ERGabsent) at 6 yrs. (i) Fundus of the littermate R42 and R46 
shown in Fig. 2b,c, imaged at 5 yrs. R46 (cone ERGabsent) showed initial signs of dark and mottling discoloration 
extending from the dorsal periphery while the R42 (normal cone-ERG) remained relatively normal.
www.nature.com/scientificreports/
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tendency for the double homozygotes (RPGRIP1ins/insMAP9del/del) to have a more severe phenotype, with earlier 
onset and faster progression.
Fundus images captured by confocal scanning laser ophthalmoscope (cSLO) revealed changes com-
parable to those visualized by ophthalmoscope. Changes in the ONL thickness over time were deter-
mined by sd-OCT. In animals younger than 1 year, retinal structure and thickness were within normal 
limits. However, with age, sd-OCT revealed progressive reduction in ONL thickness among some of the 
cone ERGabsent mutants (Fig. 3c–e). These degenerative changes were observed in all quadrants of the 
Figure 4. Abnormal cone photoreceptor structure in cone ERGabsent RPGRIP1ins/ins retina. (a) Double-
immunolabelling of retinal cryosections with antibodies against rod opsin and human cone arrestin (hCAR) 
in WT (a1), RPGRIP1+/insMAP9+/+ (a2), and RPGRIP1ins/ins MAP9+/+ animals that are normal (a3) or cone 
ERGabsent (a4). All samples had comparable rod structure with normal localization of rod opsin while the cone 
ERGabsent retina showed short cone OS and IS. The contours of representative cones have been outlined for each 
group. (b–g) Representative images of the retina double labelled with hCAR and S-opsin (b–d) or L/M-opsin 
(e–g) at 3 different positions relative to ora serrata in WT (b1–3, e1–3), normal (c1–3, f1–3) or con ERGabsent 
(d1–3, g1–3) RPGRIP1ins/ins retinas. White arrows indicate mislocalization of L/M-opsin in the cone ERGabsent 
retina which was observed at most of the retinal locations examined (g1–3). (h) Number of S- (h1) and L/M-
cones (h2) per 558μm field in WT and normal or cone ERGabsent RPGRIP1ins/ins retinas. Each cone population 
was counted in the superior retinal quadrant starting −500 μm from the ora serrata towards the optic disc every 
2,000μm. Error bars represent standard errors for groups of n = 3, and ranges (dotted line) for the group where 
n = 2. OS, outer segment; IS, inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer. (i) Confocal 
microscopy images showing immunolabelling of WT and RPGRIP1in/ins (normal cone ERG and cone ERGabsent) 
retinas with antibodies against L/M-opsin and S-opsin. Extensive opsin mislocalization to the cell body, axon, 
and synaptic pedicles were seen in the plasma membrane of L/M-cones, and rarely in S-cones (arrows) of the 
cone ERGabsent RPGRIP1ins/ins retina. Scale bar, 10 μm.
www.nature.com/scientificreports/
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retina but were most pronounced in the inferotemporal quadrant. Morphologic appearance in older subjects 
remains to be verified once tissues become available for analysis. Again, the double homozygotes (RPGRIP1ins/ins  
MAP9del/del) had a more severe phenotype with rapidly progressing ONL thinning starting as early as 17 months of age 
compared to the RPGRIP1ins/insMAP9+/del animals where ONL changes could not be visualized by sd-OCT until 4 years 
of age (Supplemental Table 3a). Notably, the one RPGRIP1ins/insMAP9+/+ animal (R17) with normal cone ERG has not 
shown ONL changes for up to 7 years of age. Together these data suggest that the additional defect in MAP9 leads to a 
more severe phenotype among the RPGRIP1ins/ins animals.
Abnormal cone photoreceptor structure in cone ERGabsent RPGRIP1ins/ins retina. Due to the 
cone-specific nature of the ERG phenotype, cone photoreceptor structures were examined in normal and cone 
ERGabsent RPGRIP1ins/ins retinas. IHC using anti-human cone arrestin (hCAR) revealed a striking difference in the 
cone structure of cone ERGabsent retinas, where both the OS and IS were shortened (Fig. 4a4). While most cone 
OS were extremely small, some rare apparently normal cone OS were also observed. Cone OS that appeared frag-
mented and/or elongated most likely represented tissue processing artifacts. The overall structural differences in 
the cone ERGabsent RPGRIP1ins/ins retinas vs retinas of other phenotypic/genotypic groups were significant enough 
to allow easy distinction. Rod photoreceptors were normal with correct rod opsin localization in all the sample 
groups (Fig. 4a).
Opsin mislocalization but no cone photoreceptor loss in the cone ERGabsent RPGRIP1ins/ins ret-
ina. To differentiate and characterize the two cone types, we examined the cone visual pigments (L/M- and 
S-opsins) that are normally expressed in the OS outer membrane of the respective cone types. Retinal cryo-
sections of young (9–11 mon) RPGRIP1ins/ins animals and controls were used for IHC. Most strikingly, the OS 
of the cone ERGabsent RPGRIP1ins/ins retina were shorter, and as a result, had a more limited area of L/M-opsin 
immunolabelling consistent with the short OS structure; as well there was extensive L/M-opsin mislocalization 
to the plasma membranes of IS, cell body and synaptic pedicles (Fig. 4g,i). Consequently, the overall L/M-opsin 
labelling intensity in these retinas was not different from that of WT and cone ERG normal RPGRIP1ins/ins retinas, 
and only differed in distribution. S-opsin labelling pattern was comparable across the different sample groups, 
with only rare and subtle S-opsin mislocalization observed in the cone ERGabsent RPGRIP1ins/ins retina (Fig. 4d,i).
Figure 5. Representative immunolabelling show reduction/absence of some cone transduction proteins. 
(a) Under confocal microscopy, the representative cone ERGabsent RPGRIP1ins/ins retina (a4) had faint GNB3 
labelling of both of the shortened OS and IS while the other samples have distinct cone OS-specific labelling 
(a1–3). (b) PNA labelling showed cone matrix sheath in all samples groups. In the cone ERGabsent retina, the 
sheaths appeared irregular corresponding to the abnormal cone structure (b4). (c–l) Double-immunolabelling 
with cone OS proteins and S- or L/M-opsin. Each image comprises of green and red channels, and the merged 
image with DAPI. For WT and normal RPGRIP1ins/ins retinas, all the proteins co-localized with S- or L/M- opsin 
at the cone OS (1–3 of c–l). However, immunolabelling of these proteins in the cone ERGabsent RPGRIP1ins/ins  
retina was reduced at the OS and occasionally also labelled the IS (e4). In particular, GαT2 labelling was 
markedly reduced in both S- and L/M-cones (c4, d4: red arrows). CNGA3 was faintly labelled in the OS of L/M- 
and S-cones (i4, j4) while CNGB3 labelling was hardly detectable in S-cones (k4) and absent in L/M-cones (l4). 
*In some cases (c,d,f,h,l), images of the 4 samples labelled with the same antibodies could not be taken under 
the same illuminating condition. In those instances the imaging conditions for both the green and red channels 
are noted in the images. COS, cone outer segment; CIS, cone inner segment; ONL, outer nuclear layer, LP, laser 
power; HV, High voltage.
www.nature.com/scientificreports/
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The number of L/M- and S-cone cells were then compared between normal and cone ERGabsent retinas. The 
density of each cone type was similar between the different genotypic and phenotypic groups (Fig. 4h). Lack of 
active cell loss was also confirmed by the absence of TUNEL positive cells in all retinal quadrants in the different 
sample groups. These findings indicate that despite the shortened cell morphology and opsin mislocalization, 
there is no significant loss in the cone cell population in the cone ERGabsent retinas before 1 year of age.
Reduced or absent labelling of some photoreceptor OS proteins in the cone ERGabsent 
RPGRIP1ins/ins retina. We next assessed the expression and subcellular localization of known cone OS pro-
teins, starting with those involved in cone phototransduction. Immunolabelling of GNB3 in the cone ERGabsent 
RPGRIP1ins/ins retina showed not only OS but also IS labelling (Fig. 5a4) while the other retinal samples showed 
OS labelling only (Figs 5a1–3). Immunolabelling of GαT2 in the cone ERGabsent RPGRIP1ins/ins retina was severely 
reduced in both S- and L/M-cones (Fig. 5c,d). GγT2 showed distinct mislocalisation to the IS (Fig. 5e4,f4). GRK7 
labelling of cone OS appeared faint in the cone ERGabsent RPGRIP1ins/ins retina, with mislocalisation to the IS 
(Fig. 5g4,h4). Among the cone cGMP-gated channel proteins studied, CNGA3 was faintly labelled in the OS of 
both cone types of the cone ERGabsent RPGRIP1ins/ins retina (Fig. 5i4,j4) while CNGB3 labelling was positive in 
S- but not in L/M-cones (Fig. 5k4,l4).
Next, proteins abundantly expressed in photoreceptor OS that are involved in both rod and cone photot-
ransduction were studied (Fig. 6). These included GNB5 (G-protein b subunit 5) that stabilizes the GAP 
(GTPase-activating protein) complex, RGS9 (GTPase-activating protein regulator of G-protein signalling 9) and 
R9AP (RGS9-anchoring protein). All three proteins labelled the OS of both rods and cones (S- and L/M-) for all 
the retinal samples (Fig. 6a–f). Labelling of GC1 was also present in both rods and cones for WT and cone-ERG 
normal retinas (Fig. 6g1–3,h1–3). However, GC1 labelling in the cone ERGabsent RPGRIP1ins/ins retina was extin-
guished in the cone cells while the rod OS labelling was mildly reduced (Fig. 6g4,h4).
To study the structure of the cone matrix sheath, retinal sections of the cone ERGabsent retina and controls were 
labelled with peanut agglutinin (PNA). Although the cone ERGabsent retina showed positive labelling, the labelling 
appeared fuzzy and the cone sheath was diminished, consistent with the presence of cones with shortened cone 
OS (Fig. 5b).
Positive photoreceptor sensory cilia labelling of cilia proteins in all the retinal samples. Proper 
functioning of photoreceptors requires continual transport of proteins, lipids, and metabolites from the IS to OS 
through the cilia, and its disruption can impact cone-derived photopic vision. RPGRIP1 has been localized to 
the cilia and is thought to function by anchoring key trafficking proteins to the cilia. Therefore, ciliary structures 
were studied using a panel of ciliary markers. Rootletin, which is a structural component of the ciliary rootlet 
and supports the basal bodies and the cilia, was found in the transition zone and photoreceptor OS in all the 
retinal samples (Fig. 7a,b). Comparable labelling patterns across the different retinal samples were observed for 
Figure 6. Cone ERGabsent retina lacks immunolabelling of GC1 but not of other photoreceptor proteins. Retinal 
cryosections were labelled with photoreceptor proteins, co-labelled with S-opsin or L/M-opsin for the same set 
of animals used in Fig. 5, and imaged in confocal microscopy. Each image comprises of green, and red channels, 
and the merged image with DAPI. In most cases, equal condition was applied to image the pictures for all 4 retinal 
samples per double-immunolabelling. Occasionally, different conditions for laser power (LP) and high voltage 
(HV) were used so that protein localization could be visualized in samples with low labelling intensities (*).  
In such cases, the settings used for imaging the green and red channels are indicated in the picture (b,c,h).  
(a–f) Representative images showing labelling of GNB5, RGS9, and R9AP in the OS of rods and cones  
(S and L/M) in all four retinas. (g,h) GC1 localized in the OS of rods and both cone types in WT and normal 
RPGRIP1ins/ins retinas. However, the cone ERGabsent RPGRIP1ins/ins retina lacked distinct GC1 co-labelling with 
either cone types (g4, h4). GC1 labelling of rod OS in h4 is indicated by a white double arrowhead. Rare S-opsin 
mislocalization to the cell body are indicated by white arrows (e4, g4).
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additional ciliary proteins including acetylated α tubulin (Fig. 7c,d) and MAP9 (Fig. 7e,f). Immunolabelling 
of acetylated α tubulin appeared to correspond to the transition zone as well as the OS axoneme while MAP9 
labelled the transition zone only. The length of labelling by some ciliary markers, namely acetylated α tubulin and 
MAP9 appeared generally shorter in the cone ERGabsent retina compared to RPGRIP1+/ins or normal RPGRIP1ins/ins 
for both L/M- and S-cones (Fig. 7c4–f4). However, artifactual retinal separation from the RPE leading to OS/
IS distortion limited the evaluation of the ciliary length. While the implication of potentially shorter cilia in the 
disease is unclear, its association with cone dysfunction implies that it may disrupt normal ciliary trafficking.
Normal non-ciliary vesicular transport and dendritic terminals with no inner retinal stress in the 
cone ERGabsent RPGRIP1ins/ins retina. To determine if mislocalization of the cone opsins from the OS was 
due to a general defect in vesicular trafficking, another class of vesicles associated with the synapse was studied. 
Antibodies against proteins localized at the synaptic terminals (synaptophysin, SNAP25 and CtBP2) showed 
typical punctate labelling of synaptic boutons in both the outer (OPL) and inner (IPL) plexiform layers of all the 
retinal samples (Supplemental Fig. S2a–c), indicating normal formation of the synaptic vesicles. As glial cells play 
a critical role in maintaining retinal structure and function, and are one of the first responders to retinal stress, 
we next labelled retinal sections from all the groups with an antibody against the stress-induced protein, glial 
fibrillary acidic protein (GFAP). GFAP expression pattern was comparable in all the retinal samples, indicating 
absence of inner retinal stress at the early age studied (Supplemental Fig. S2b). Further, dual-labelling with anti-
bodies against Goα and PKCα that are markers of ON- and rod-bipolar cells, respectively, showed comparable 
number of rod and cone-BCs in all the retinal samples. There was no apparent retraction of dendritic terminals 
(Supplemental Fig. S2d), and the structure of secondary neurons appeared normal.
Changes in protein and mRNA levels among selected retinal genes. To quantitate the expres-
sion levels in selected retinal proteins that represent the different retinal cells or compartments (i.e. cones and/
or rods, cilia), Western blot was performed using WT (n = 3) and RPGRIP1ins/ins (3 normal, 3 cone ERGabsent) 
retinas (Fig. 8). In agreement with the IHC findings, the expression of photopigments (Rhodopsin, S- and 
L/M-opsins) were comparable between the different sample groups. Of note, expression of rhodopsin (RHO) 
was reduced at the mRNA level in 2 of the 3 cone ERGabsent samples, compared to WT or normal RPGRIP1ins/ins 
retinas (Supplemental Fig. S3). However, quantitation at the protein level revealed minimal reduction (Fig. 8). 
Of the cone-specific proteins, CNGA3 expression was comparable across the groups while CNGB3 was sig-
nificantly down-regulated in the cone ERGabsent retina, consistent with the lack of CNGB3 immunolabel-
ling in the more numerous L/M-cones (Fig. 5l4: faint CNGB3 immunolabelling visible with increased laser 
intensity shows colocallizing with L/M-opsin). GC1, expressed in both rods and cones, was significantly 
down-regulated not only in the cone ERGabsent RPGRIP1ins/ins retinas but also in the normal RPGRIP1ins/ins. 
The reason for the inconsistency between the IHC and Western data for the latter group is unclear. Finally, 
ciliary proteins RPGRIP1 and MAP9 whose mutation have been associated with cord1, and NPHP4 which 
is an interacting protein of RPGRIP1 were quantitated, revealing no differences in expression between the 
different sample groups. Where data is available, quantitative analysis of mRNA and proteins are mostly in 
line with the IHC findings including significant reduction in CNGB3 and GC1 in the cone ERGabsent mutant. 
Next, mRNA levels of genes expressed in specific types of retinal cells were quantitated for a panel of genes 
including rod-only and cone-only expressed genes, as well as those expressed in synaptic terminals (SNAP25), 
and in photoreceptors and bipolar cells (GNB5, RGS7BP, RGS9BP and RGS11). WT (n = 3) and RPGRIP1ins/ins 
MAP9+/+ (2 normal, 3 cone ERGabsent) retinas were used to examine any alteration associated with the 
Figure 7. Shorter photoreceptor sensory cilium in the cone ERGabsent RPGRIP1ins/ins retina. Retinal cryosections 
from the same set of animals used in Fig. 5 were labelled with ciliary proteins rootletin (a,b), acetylated 
α-tubulin (c,d), and MAP9 (e,f), co-labelled with S-opsin or L/M-opsin, and imaged in confocal microscopy. 
The lower part of each representative image comprises of green and red channels, and the merged image with 
DAPI. The upper part of the panel shows a magnified version of the area outlined in the lower merged image.
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phenotype. While qRT-PCR revealed substantial intra-group variation, there was no significant difference in 
expression levels across the different sample groups for any of the selected genes (Supplemental Fig. S3). Still, 
in concordance with the protein expression levels, CNGB3 had overall decreased mRNA expression in the 
cone ERGabsent RPGRIP1ins/ins mutants. Likewise, GUCY2D that encondes GC1 had overall decreased mRNA 
in the both normal and cone ERGabsent RPGRIP1ins/ins mutants.
Discussion
The RPGRIP1ins/ins mutation was previously associated with a canine CRD6 in a closed research colony, charac-
terized by diminished cone ERG5 within months after birth, followed by loss of rod photoreceptor functions, 
leading to complete blindness by 2 years of age4. More recently, among the RPGRIP1ins/ins animals in the general 
breed population, a MAP9del/del mutation has been identified as a modifier leading to early onset of the disease9,10. 
Although the revised digenic (RPGRIP1 and MAP9) model initially seemed to explain the broad range of disease 
onset in the general breed population, our study herein of an extended RPGRIP1ins/ins canine colony found strik-
ing variability in cone-ERG ranging from normal, reduced to absent while retaining normal rod function. These 
variable cone ERG features were present at the earliest age ERG could be performed in puppies, and remained 
largely unchanged when repeated over time, with only minor fluctuations in cone ERG amplitudes. The variation 
in cone ERG phenotype in RPGRIP1ins/ins animals did not appear to be associated with their MAP9 genotype 
(discussed later), suggesting an additional genetic mechanism contributing to the observed phenotypic variation.
We expected that photopic vison of cone ERGabsent mutants would be defective based on the lack of cone photo-
receptor response using full-field photopic ERG. Interestingly, however, vision-guided behaviour test performed 
in a cone ERGabsent animal and its normal and genotype-matched sibling demonstrated comparable results, even 
Figure 8. Comparable expression of photoreceptor proteins except CNGB3 and GC1 by Western blot. Western 
blot of selected photoreceptor proteins were performed using retinal protein extracts from WT (n = 3) and 
RPGRIP1ins/ins mutants that were either normal (n = 3) or cone ERGabsent (n = 3). (a) Quantitation of proteins on 
western blot performed with Li-COR Odyssey software showed significant down-regulation of CNGB3 in the 
cone ERGabsent RPGRIP1ins/ins retina compared to WT (*p = 0.004) or normal RPGRIP1ins/ins retina (*p = 0.011), 
and of GC1 in the normal (*p = 0.009) and cone ERGabsent (*p = 0.0005) RPGRIP1ins/ins retina with respect to the 
WT. Error bars represent standard errors. (b) Representative western blot images for each WT, RPGRIP1ins/ins 
with normal or cone ERGabsent retinas for each of the marker studied are shown side by side along with internal 
control ACTB. The molecular weight (kDa) of specific immunolabelled bands is indicated.**Anti-canine 
RPGRIP1 antibody designed to recognise the C-terminus immunolabelled a smaller isoform compared to the 
expected full-length protein of ~160 kDa. The images of bands for the target protein and ACTB are taken from 
the same blot and each image has been cropped as delineated by black dividing lines, as well as adjusted for 
image intensity for optimal visualization.
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at a high light intensity where cones are predominantly used for vision. Of note, CNGB3-achromatopsia dogs with 
complete cone dysfunction have significant defects in navigation at high light intensity when assessed in the same 
obstacle course11. The comparable behaviour between the cone ERGabsent and normal RPGRIP1ins/ins littermate 
remained stable for up to 5.5 years based on repeated obstacle course trials (ref.8 and present study). Our findings 
indicate that the cone ERGabsent mutants have residual cone function that is under the threshold of full-field cone 
ERG, but surprisingly permits photopic vision sufficient for navigation.
Along with the functional ERG assessment of the retina, we also examined morphological changes of the 
retina that are clinically observable by ophthalmoscopy or sdOCT. Morphological changes typically emerge later 
than ERG abnormalities, which are commonly observed at the early stage of retinal degenerative diseases. Some 
of the cone ERGabsent RPGRIP1ins/ins eyes did develop ophthalmoscopic abnormalities over time when followed up 
long term. Of the changes observed, increased reflectivity of the tapetal fundus, multifocal depigmentation in the 
non-tapetal fundus, and attenuation of retinal vasculature are hallmarks of inherited retinal degenerative diseases 
in canines. However, the most striking change observed in the cone ERGabsent RPGRIP1ins/ins animals was the 
presence of dark discolouration of the tapetal fundus, which may represent retinal thinning, pigment migration, 
or a combination of both. While sd-OCT scanning of these dark discoloured regions indicated mild to moderate 
thinning of the ONL, the disease process at the cellular level awaits future histologic and immunohistochemical 
examination of retinas with advanced disease.
To study the clinically observed retinal changes at the cellular level, we examined retinal cryosections of WT, 
RPGRIP1+/ins and RPGRIP1ins/ins (normal and cone ERGabsent) in young animals, at age 9–11 months. H&E his-
tology revealed comparable thickness of the retina and ONL across the samples studied, consistent with the 
sd-OCT findings at this age group. However, immunolabelling of specific retinal cells and their protein com-
ponents revealed striking changes in the cone ERGabsent RPGRIP1ins/ins retina. Morphologically, both L/M- and 
S-cones were markedly shortened in the cone ERGabsent RPGRIP1ins/ins retina, with shorter IS, OS and photore-
ceptor sensory cilia. In addition, while the overall expressions of L/M- and S-opsins were comparable quantita-
tively across the different retinal samples studied by Western, IHC revealed extensive L/M-opsin mislocalization 
to the cell membranes of the IS, soma and synaptic pedicles in the cone ERGabsent RPGRIP1ins/ins retina, as assessed 
by confocal microscopy. These indicate: A) defective protein trafficking from the L/M-cone cell body through the 
IS and cilia to the OS giving rise to a small OS; B) primary formation of shortened cone OS that is not capable of 
accommodating normal levels of proteins resulting in diversion of L/M-opsin to elsewhere within the L/M-cone, 
or a combination of both, providing a potential explanation for cone dysfunction. Of note, the S-opsins of the 
less numerous S-cones were only rarely mislocalized and to a lesser degree, indicating a primary L/M-cone defect 
in the cone ERGabsent RPGRIP1ins/ins animals. As these findings suggested that the intact S-cones might provide 
sufficient photopic vision for navigation, L/M- and S-cone functions were tested separately using chromatic 
ERGs. Results showed that S- and L/M-cone derived ERGs were equally affected in the cone ERGabsent and cone 
ERGreduced RPGRIP1ins/ins animal (Supplemental Fig. S1). These results, together with the shorter morphology 
observed in both cone types, support a pathogenesis that affects both L/M- and S-cones.
Our immunolabelling studies further revealed that the level of specific cone transduction proteins was 
reduced in the cone ERGabsent RPGRIP1ins/ins retina, with CNGB3 being undetectable in L/M-cones and only 
faintly labelled in S-cones. Western blot analysis showed significantly reduced expression of CNGB3 in the cone 
ERGabsent RPGRIP1ins/ins retinas (p ≤ 0.011), supporting the IHC findings. Mutations in CNGB3, the beta subunit 
of the cyclic nucleotide-gated channels in cones, are associated with loss of cone function leading to achromatop-
sia (day blindness) in humans and in certain canine breeds11–14. However, our cone ERGabsent RPGRIP1ins/ins ani-
mal retains sufficient photopic vision, suggesting that the observed reduction in CNGB3 is a secondary effect of 
the diseased cones, rather than a primary defect as in CNGB3-achromatopsia. Loss of CNGB3 has been associated 
with loss of its heterotetrameric partner CNGA3 since it regulates the expression of CNGB3 as was shown in the 
mouse model of CNGA3-achromatopsia before and after gene therapy15. However, the role of CNGA3 primarily 
down-regulating CNGB3 in the cone ERGabsentRPGRIP1ins/ins retina is less likely as our IHC and Western data 
show that CNGA3 is not significantly affected.
We also studied the expression of proteins that are generally expressed in both rods and cones. Of the proteins 
assessed, labelling of GC1 in the cone ERGabsent retina was undetectable in both cone types while the rods had 
normal GC1 labelling. Western blot analysis showed significantly reduced overall GC1 expression in the cone 
ERGabsent retina reflecting the GC1 loss. GC1 is encoded by GUCY2D and restores intracellular cGMP levels and 
allows reopening of cGMP-gated cation channels in both rods and cones. While GUCY2D that encodes for GC1 
is one of the most frequently mutated genes associated with Leber congenital amaurosis16–18, GUCY2D mutations 
have also been associated with cone-rod dystrophy 6 (CORD6) in humans19–21. GC1 stabilizes cone transducin 
and cone PDE22 but the mechanism by which defects in GC1 primarily affect cone function in CORD6 patients 
remains unexplained. The cone-specific loss of GC1 in the cone ERGabsent RPGRIP1ins/ins retina may be a second-
ary change in response to the cone morphological and functional abnormalities, or may reflect a primary genetic 
defect in GUCY2D. Genome-wide mapping and sequencing to search for genetic changes associated with the 
cone ERG defect are under way and will help determine if changes in GC1 contribute to the phenotypic variability 
observed in our RPGRIP1ins/ins colony.
Finally, known cilia markers were assessed to determine if there were potential alterations in morphology 
that may impact ciliary function. The cilia were of particular interest because the two disease-associated genes 
RPGRIP1 and MAP9 are both localized to the cilia21,23. Microtubules (MTs) are important elements of the ciliary 
structure and cytoskeletons. MT acetylation causes the motor proteins kinesin and dynein to bind to MTs thereby 
aiding in cellular transport24. Examination of the MT kinetics focusing on the balance between acetylation and 
de-acetylation of cilia in an ERGabsent RPGRIP1ins/ins background might shed light on the molecular pathogene-
sis. While the role of MAP9, one of many microtubule-associated proteins (MAPs), in retinal homeostasis and 
function remains to be established, our IHC data show localization of MAP9 in the transition zone of the cilia of 
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both rods and cones. Localization of RPGRIP1, thought to anchor the protein complexes25, to the same region as 
MAP9 supports a potential role for MAP9 as a modifier of RPGRIP1 function.
To quantitate the expression of some of the photoreceptor-expressed proteins, Western blotting analysis was 
carried out. The findings were largely in line with that of IHC that showed significantly reduced expression of 
CNGB3 and GC1 in the cone ERGabsent RPGRIP1ins/ins retina. The cilia proteins, including RPGRIP1 and MAP9 
that are associated with cord1, were also examined by Western blot revealing comparable expression between WT 
and RPGRIP1ins/ins retinas both normal and cone ERGabsent. It is important to note that our custom anti-canine 
RPGRIP1 antibody against the C-terminal RID domain, identified a single product of 45 kDa which corresponds 
to a truncated isoform, rather than the full-length ~160 kDa product. As the expression pattern was comparable 
regardless of the presence or absence of the RPGRIP1ins/ins mutation, the truncated product likely represents an 
RPGRIP1 isoform that does not utilize the insertion mutation site but includes the C-terminal RID against which 
the custom canine antibody was designed to recognize. The presence of smaller isoforms is supported by previous 
studies where extensive RPGRIP1 isoforms were identified arising from complex splice variants as well as alterna-
tive start codons found in the retina of dogs26,27 and in other species including humans28. In particular, an isoform 
with an alternative start codon (chr15:18,352,430–18,352,432; CanFam3.1) in canine exon 13 as verified by 5′ 
RACE experiments27 leads to a truncated product corresponding to that identified in our current study. While the 
predicted full-length transcript of ~160 kDa encompassing most of the exons was not identified by our custom 
antibody, Castagnet et al. was able to detect a ~160 kDa product using an antibody (Ab38) that was also designed 
to recognize the domain RID, albeit with longer exposure of the blot28. That antibody, when used in canine retinal 
protein extracts, only identified the lower molecular weight isoforms8, and it is possible that the differences in 
extraction methods of retinal proteins for Western analysis are responsible. Based on these findings, studies are 
ongoing to investigate the role of the truncated RID-containing isoform, as well as the basis of the technical chal-
lenges in capturing the full-length product both at the transcript and protein levels.
While assessment of the protein expression was limited by the availability of antibodies that cross-react with 
canine tissue, retinal transcript levels of a panel of genes preferentially expressed in either rods, cones, or synaptic 
terminals were assessed by qRT-PCR. For the genes expressed in rods, cones, and synaptic terminals studied, 
there was no difference at the mRNA level between WT and normal or cone ERGabsent RPGRIP1ins/ins retinas. This 
indicates that transcript expression of the selected genes was not affected by the functional and morphological 
changes of cones in the cone ERGabsent retina. While only a few selected retinally expressed genes are studied 
herein, global changes in retinal transcripts are being investigated by total transcriptomic study. This on-going 
approach will not only extend the current qRT-PCR data to a comprehensive profile of the transcriptome, but will 
also aid in identifying transcripts that might contribute to the variation in cone ERG phenotype that we observe.
As the current research colony was being established, we primarily focused on generating RPGRIP1ins/ins 
animals, allowing the MAP9 mutation to segregate naturally. Of the eight double homozygotes (RPGRIP1ins/ins-
MAP9del/del) that were generated, all exhibited a cone ERGabsent phenotype with early and rapidly-progressing 
retinal changes, suggesting that the MAP9del/del modifier might have a role in exacerbating the retinal phenotype. 
However, as RPGRIP1ins/ins animals of any MAP9 genotypes were found to show the cone ERGabsent phenotype in 
the current colony, we conclude that MAP9 del/del is not essential for the development of an abnormal cone ERG 
phenotype. Based on the morphological data in the cone ERGabsent retina, we hypothesize that an additional gene 
product that contributes to the formation or maintenance of cone morphology is associated with the cone ERG 
phenotype. This locus may have been present but fixed in the original research colony leading to a more severe 
phenotype (the “classic” cord1), and hence only a single strong linkage in the first study. Later on when we bred 
dogs from outside this original colony and one female impregnated with the semen of Casper from the original 
colony to develop our own colony of dogs, events of recombination occurred at the fixed genotype and the third 
gene naturally segregated with the cone ERG phenotype. Alternatively, outcrossing in our current colony may 
have introduced a new locus that has a protective or alleviating effect. We will examine these hypotheses once 
the locus corresponding to the cone ERG phenotype is mapped and candidate gene mutation identified in our 
on-going studies.
In conclusion, RPGRIP1ins/ins animals in the canine colony reported herein show a spectrum of phenotypes 
ranging from normal, cone ERGreduced, to cone ERGabsent that does not segregate with the known modifier MAP9. 
Morphologically, the cone ERGabsent RPGRIP1ins/ins retina has shortened cones, accompanied by down-regulation 
of key transduction proteins such as CNGB3 and GC1. While RPGRIP1ins/ins and MAP9del/del have previously been 
associated with cord1 and their roles in disease pathogenesis remain important, neither one alone is sufficient to 
manifest the disease. The involvement of an additional locus responsible for the cone morphological and func-
tional defects is indicated, and its identification will allow a unique opportunity using this canine model to tease 
out the pathogenesis and gene/protein interactions of a multigenic form of inherited retinopathy that has been a 
challenge to study in genetically diverse human populations.
Material and Methods
Ethics statement. The research was conducted in full compliance and strict accordance with the Association 
for Research in Vision and Ophthalmology (ARVO) Resolution on the Use of Animals in Ophthalmic and 
Vision Research, and the Policies on the Use of Animals and Humans in Neuroscience Research of the Society 
of Neuroscience. The protocol was approved by the host institute’s IACUC (number: 801870). While none of the 
procedures were expected to cause discomfort, all efforts were made to minimize potential suffering of the animals.
Colony establishment. The canine research colony was established by outcrossing two unrelated pure-
bred RPGRIP1ins/ins MLHDs to unrelated mix breed dogs, and subsequently expanded by backcrossing and 
inter-crossing (Fig. 1). The colony was maintained at the Retinal Disease Studies Facility at the University of 
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Pennsylvania. Briefly, semen from an RPGRIP1ins/ins dog (Casper), obtained from the previously described cord1 
research colony at the Animal Health Trust, Lanwades Park, Newmarket, UK4,6 was used to inseminate one nor-
mal female (N220). The mutant founder had typical cord1 features and showed early-onset generalized retinal 
degeneration with diminished 30-Hz cone flicker ERG response that further decayed in the first year of life5. An 
unrelated female RPGRIP1ins/ins MLHD (R10) affected with advanced end-stage retinal degeneration at 2.6 yrs was 
the second founder of the colony. Breeding with a male RPGRIP1+/+ MLHD (R9) resulted in a litter (R11-R15) 
of heterozygotes having clinically normal vision and ERG. Subsequent breeding among the F1 progeny gave rise 
to RPGRIP1ins/ins mutants8.
Animals. Sixty-four related dogs from the purpose-bred cord1 research colony (Fig. 1) were included in the 
study. In addition, WT normal dogs unrelated to the colony were included for IHC (n = 3) and qRT-PCR (n = 3). 
All the animals were genotyped for the presence of RPGRIP1ins/ins and MAP9 mutations (Fig. 1) as previously 
described6,10. The pedigree illustrates the genotypes at RPGRIP1 and MAP9 loci and the ERG functions studied.
Ophthalmic examinations. Each dog underwent comprehensive ophthalmic examinations at 6–18 
wks, and approximately every 6 months thereafter. The fundus was examined by indirect ophthalmoscopy. A 
hand-held fundus camera (RC-2; Kowa Ltd, Nagoya, Japan) or a contact retinal camera (RetCam Shuttle; Clarity 
Medical Systems, Pleasanton, CA, USA) was used for fundus photography.
Electroretinography (ERG). Following pupillary dilation, full-field flash ERG was performed as detailed 
previously29, on both eyes under general inhalation anaesthesia (induction with IV propofol; maintenance 
with isofluorane) using a custom-built Ganzfeld dome fitted with the LED stimuli of a ColorDome stimulator 
(Diagnosys LLC, Lowell, MA, USA). To independently assess L/M- and S-cone functions, light adapted full-field 
ERGs were performed using different colour background lights and light flashes. The background was produced 
by LED lights at an intensity of 32.35 (S) cd*s/m2, and the flashes were produced by LED lights of increasing 
intensity. Briefly, L/M-cone mediated responses were elicited by using increasing intensities of yellow light flashes 
(3.235, 16.18, and 22.65 (S) cd*s/m2) on a blue background, followed by increasing intensities of green light 
flashes (3.235, 16.18, and 22.65 (S) cd*s/m2) also on a blue background. S-cone mediated responses were elicited 
by using increasing intensities of blue flashes (3.235, 16.18, and 22.65 (S) cd*s/m2) on white followed by yellow 
backgrounds. Animals were adapted for each new background colour for 10 min.
Visual Behaviour Testing. A 3.6 m-long custom made obstacle course was used to evaluate visually guided 
behaviour as described previously30, under ambient (0.2, 1, 10, 65, and 646 lux) and lower (0.003, 0.009, and 0.2 
lux) illuminations. The obstacle panels were changed each time a new test run was performed. Two RPGRIP1ins/ins 
littermates, one with normal and the other cone ERGabsent, were initially tested at 4 mon. The performance was 
previously reported from 6 through 10 mon8. Here the long-term follow up (over a 5.5-year period) of the animals 
have been studied with assessments done every 1–6 months.
Spectral domain optical coherence tomography (sd-OCT). In vivo imaging was done using the 
same general anaesthesia protocol by using a combined cSLO/sd-OCT instrument (Spectralis HRA + OCT, 
Heidelberg, Germany). Briefly, overlapping en face images of reflectivity with near-infrared illumination (820 nm) 
were obtained with a 55° lens to delineate fundus features such as optic nerve, retinal blood vessels, and other 
local changes. A 30° lens was used to perform sd-OCT with linear and raster scans. Overlapping 30° × 20° ras-
ter scans (120 µm (9 ART) × 49 sections) were recorded covering large regions of the retina. The outer nuclear 
layer thickness was measured by manual segmentation using the analysis tool that accompanied the instrument 
software.
Tissue collection. Retinal tissues were promptly harvested from selected dogs following euthanasia 
(Euthasol; Virbac, Fort Worth, TX, USA). Posterior eye cups were collected for histology and IHC from a group 
of age-matched dogs (9–11 mon): 1 RPGRIP1+/ins, 2 normal and 3 cone ERGabsent RPGRIP1ins/ins, and 3 WT con-
trol dogs (2–5 yrs) unrelated to the research colony.
Histology and IHC. The posterior eye cups were processed as previously described31. H&E-stained 10 µm 
sections from the superior quadrant were used to quantitate ONL and INL thickness (µm) and cell counts were 
indicated by rows of nuclei. Beginning 1,000 µm from the ora serrata, and extending centrally at 1,000 µm inter-
vals, the number of rows of nuclei was determined in three areas of a 558μm length visual field.
For IHC, cryosections were incubated overnight with appropriate primary antibodies (Supplemental Table 1) 
in dilution buffer (4.5% fish gelatin, 0.1% sodium azide and 5% BSA in PBST). Heat-induced epitope retrieval 
was performed in all cases (except PNA) prior to primary antibody treatment by incubating the sections in citrate 
buffer (pH = 6) at 125 °C for 10 min in a pressure cooker. In all cases, antigen-antibody complexes were visualized 
with fluorochrome-labelled secondary antibodies (Alexa Fluor Dyes, Molecular Probes, Invitrogen, Carlsbad, 
CA, USA) with 1:200 dilution. Slides were examined under 20X and 40X objectives on an epifluorescence micro-
scope (Axioplan; Carl Zeiss Meditec, Oberkochen, Germany). Images were digitally photographed from the same 
retinal regions in the 4 samples with a Spot 4.0 camera (Diagnostic Instruments, Inc., MI, USA). Some slides were 
visualized under Nikon A1R confocal microscope (Nikon Instruments Inc. NY, USA) at 60x and 100x, and digital 
images were captured and processed using the NIS Elements software (Nikon Instruments Inc.). The settings for 
capturing images in the microscopes were constant in all samples for each antibody except for those cases where 
changes were necessary to better visualize the localization of down regulated proteins, and the settings have been 
indicated in the images.
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TUNEL Assay. To look for cells dying through apoptosis in the cone ERGabsent retina, TUNEL assay was done 
on all quadrants of retinal tissue sections in WT, RPGRIP1+/ins and RPGRIP1ins/ins (normal and cone ERGabsent) 
according to the manufacturer’s protocol (in situ cell death detection kit; Roche Diagnostics Corporation, IN, 
USA), stained with DAPI, and visualized under fluorescence microscope.
Genotyping RPGRIP1 insertion and MAP9 deletion. All animals born in the colony were genotyped 
for RPGRIP1 insertion (primer sequences listed in Supplemental Table 2a) and MAP9 deletion using the primer 
pairs described by Forman et al.10.
RNA extraction, cDNA synthesis and quantitative Real time PCR (qRT-PCR). Whole retinas were 
isolated from the eyecups within 1–2 min of euthanasia and flash frozen in liquid nitrogen and stored at −80 °C. 
Retinal RNA was extracted using Trizol method from 3 WT controls (1 M, 2 F; 7–14 mon), normal (2 M, 1 F; 
9–11 mon) or cone ERGabsent (1 M, 5 F; 9 mon) RPGRIP1ins/ins mutants, DNase I (Ambion, Carlsbad, CA, USA) 
treated, and reverse-transcribed. Due to limited tissue availability, three of the six available cone ERGabsent retinas 
as indicated as blue asterisk in Fig. 1 was used for a given gene analysis. Briefly, 20ng of cDNA was used in a total 
reaction volume of 10 μl in a 384-microwell plate and run on a 7900HT fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA). For each sample, 3 technical replicates were run. Supplemental Table 2b pro-
vides details of all the genes and qRT-PCR primers (SYBR-green, TaqMan). Fold change was calculated by ∆∆CT 
method32. Cut off for fold change was set at ≥±2 for differential expression.
Western blot analysis. Retinal proteins were extracted by standard method using T-PER™ reagent (Thermo 
Fisher Scientific, Rockford, IL, USA) and quantitated by BCA Protein Assay Kit (Thermo Fisher Scientific). Each 
sample was denatured in 1x Laemmli sample buffer (Bio-Rad, Hercules, CA)-5% 2-mercaptoethanol at 95 °C 
for 5 min. 30 µg total protein was loaded in triplicate on a precast gel having 1x SDS/Tris/Glycine buffer. The gel 
was subsequently wet transferred into a nitrocellulose membrane which was then cut to separate each triplicate 
samples, blocked with 1x Odyssey PBS Blocking Buffer (LI-COR, Lincoln, NE, USA) for 1 h at room temperature 
and probed with the primary antibody (Supplemental Table 1a) for 18 h at 4 °C. Membranes were washed with 
PBST thrice and incubated for 1 h at room temperature in fluorescent-labelled secondary antibodies (LI-COR, 
Lincoln, NE. USA). Immunoblots were washed in PBST thrice and a final wash in PBS once. Each immunob-
lot was scanned on LI-COR Odyssey Fc Dual-Mode Imaging System and normalized against β-actin using the 
LI-COR Image Studio Software. For each sample, the average of the three β-actin-normalized values per each 
antibody was compared with that of the corresponding normalized and averaged control value and expressed as 
fold-changes. Statistical significance was calculated by an unpaired t-test using Graphpad.
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